JAMMU, Sept 21: Jammu Pharmaceutical Distributors Association (JPDA) charged pharmaceutical companies of resorting to corrupt practices in the sale of medicines and thus, looting common masses of India.
While addressing a press conference here today, Rakesh Gupta, president JPDA, expressed serious concern over the shocking malpractices being adopted by the pharmaceutical manufacturing companies by selling most of the medicines at different prices to different sectors despite having the same MRP.
He said that all this was happening with active connivance of the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, Government of India, which is responsible for regulating the prices of drugs under Essential Commodities Act of the Drugs Price Control Order.
Giving details, Rakesh Gupta said that these pharmaceutical manufacturing companies are selling the medicines on different rates to different sectors like chain of stores/private hospitals/nursing homes, doctors’ clinics, online sellers, direct distributors/stockists etc. He warned both the manufacturers and the NPPA for adopting unethical practice of looting the poor patients by making money on human sufferings.
Click here to watch video
While appreciating the numerous initiatives undertaken by Prime Minister Narendra Modi in the health sector, especially the Ayushman Bharat – Pradan Mantri Jan Arogya Yogana (AB-PMJAY), Gupta expressed his displeasure that these unethical practices by the manufacturers that too right under the nose of Price Regulators and Watch Dogs of the Government of India, are resulting in loss of huge sum of money not only to the people at large but to the Government too because of different price structures with high MRPs.
The JPDA president appealed to the Chief Justice of India to take suo moto cognizance of this whole gamut and issue notice to the concerned Ministry and the pharmaceutical manufacturers to take time bound corrective steps in the larger interest of suffering humanity and sell medicines to different sectors at one price allowing a level playing field to all the stake holders which will plug all means to stop the entry of spurious /sub standard material from entering the markets.